Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $37,818 - $45,221
176 Added 0.94%
18,969 $4.17 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $233,425 - $273,560
-1,102 Reduced 5.54%
18,793 $4.24 Million
Q2 2023

Aug 07, 2023

BUY
$205.19 - $232.99 $266,541 - $302,654
1,299 Added 6.99%
19,895 $4.39 Million
Q1 2023

May 03, 2023

SELL
$212.99 - $276.17 $2.15 Million - $2.78 Million
-10,083 Reduced 35.16%
18,596 $4.16 Million
Q4 2022

Feb 10, 2023

SELL
$205.95 - $280.43 $26,361 - $35,895
-128 Reduced 0.44%
28,679 $7.98 Million
Q3 2022

Oct 24, 2022

BUY
$203.3 - $244.17 $34,154 - $41,020
168 Added 0.59%
28,807 $6.03 Million
Q2 2022

Jul 22, 2022

BUY
$174.81 - $241.14 $279,870 - $386,065
1,601 Added 5.92%
28,639 $6.75 Million
Q1 2022

May 02, 2022

BUY
$166.16 - $213.96 $1.64 Million - $2.12 Million
9,889 Added 57.67%
27,038 $4.85 Million
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $343,019 - $402,124
1,861 Added 12.17%
17,149 $3.71 Million
Q3 2021

Nov 03, 2021

BUY
$179.86 - $214.88 $2.75 Million - $3.29 Million
15,288 New
15,288 $2.82 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.